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Abstract:
Background and Aims: Little is known about the relationship between 
inflammatory bowel disease and body image. The aim of this systematic 
review was to summarise the evidence on body image dissatisfaction in 
inflammatory bowel disease patients across four areas: body image tools 
(i), prevalence (ii), factors associated with body image dissatisfaction in 
inflammatory bowel disease (iii) and association between inflammatory 
bowel disease and quality of life (iv). 
Methods: Two reviewers screened, selected, quality assessed and 
extracted data from studies in duplicate. EMBASE, MEDLINE, PsycINFO 
and Cochrane CENTRAL were searched to April 2018. Study design 
specific critical appraisal tools were used to assess risk of bias. Narrative 
analysis was undertaken due to heterogeneity.   
Results: Fifty-seven studies using a body image tool were included; 31 
for prevalence and 16 and 8 for associated factors and association with 
quality of life respectively. Studies reported mainly mean or median 
scores. Evidence suggested female gender, age, fatigue, disease activity, 
and steroid use were associated with increased body image 
dissatisfaction, which was also associated with decreased quality of life. 
Conclusion: This is the first systematic review on body image in 
inflammatory bowel disease patients. The evidence suggests that body 
image dissatisfaction can negatively impact patients, and certain factors 
are associated with increased body image dissatisfaction. Greater body 
image dissatisfaction was also associated with poorer quality of life. 
 However, the methodological and reporting quality of studies was in 
some cases poor with considerable heterogeneity. Future IBD research 
should incorporate measurement of body image dissatisfaction using 
validated tools. 
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2
20 ABSTRACT
21 Background and Aims: Little is known about the relationship between 
22 inflammatory bowel disease and body image. The aim of this systematic review 
23 was to summarise the evidence on body image dissatisfaction in inflammatory 
24 bowel disease patients across four areas: body image tools (i), prevalence (ii), 
25 factors associated with body image dissatisfaction in inflammatory bowel 
26 disease (iii) and association between inflammatory bowel disease and quality of 
27 life (iv). 
28 Methods: Two reviewers screened, selected, quality assessed and extracted 
29 data from studies in duplicate. EMBASE, MEDLINE, PsycINFO and Cochrane 
30 CENTRAL were searched to April 2018. Study design specific critical appraisal 
31 tools were used to assess risk of bias. Narrative analysis was undertaken due 
32 to heterogeneity.  
33 Results: Fifty-seven studies using a body image tool were included; 31 for 
34 prevalence and 16 and 8 for associated factors and association with quality of 
35 life respectively. Studies reported mainly mean or median scores. Evidence 
36 suggested female gender, age, fatigue, disease activity, and steroid use were 
37 associated with increased body image dissatisfaction, which was also 
38 associated with decreased quality of life.
39 Conclusion: This is the first systematic review on body image in inflammatory 
40 bowel disease patients. The evidence suggests that body image dissatisfaction 
41 can negatively impact patients, and certain factors are associated with 
42 increased body image dissatisfaction. Greater body image dissatisfaction was 
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3
43 also associated with poorer quality of life.  However, the methodological and 
44 reporting quality of studies was in some cases poor with considerable 
45 heterogeneity. Future IBD research should incorporate measurement of body 
46 image dissatisfaction using validated tools. 
47
48 Keywords: Systematic review – inflammatory bowel disease – body image – quality of 
49 life
50
51 What is already known about this subject?
52 Body image in inflammatory bowel disease (IBD) patients is relatively 
53 unexplored. However, it may potentially be an issue as symptoms and other 
54 factors associated with IBD could lead to body image dissatisfaction. Both of 
55 these conditions may lead to an increased risk of developing mental health 
56 disorders such as depression and self-harm, warranting research into the area.  
57 What are the new findings?
58 This review highlights associations between certain factors in IBD and body 
59 image dissatisfaction, as well as suggesting that increased body image 
60 dissatisfaction is related to reduced quality of life. The review also highlights the 
61 need for a validated, reliable tool to measure body image in IBD patients as well 
62 as clearer reporting of studies. 
63
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4
64 How might it impact on clinical practice in the foreseeable future?
65 Body image can be considered when making clinical decisions regarding IBD 
66 patients with the potential for interventions to improve body image in patients at 
67 risk. 
68
69
70
71
72
73
74
75
76
77
78
79
80
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81 INTRODUCTION
82
83 Inflammatory bowel disease (IBD) is associated with a range of debilitating 
84 symptoms(1) and affects around 300,000 people in the UK(2), over 1 million in 
85 the USA and 2.5 million across Europe(3). A potentially overlooked issue for IBD 
86 patients is body image dissatisfaction (BID). Body image (BI) is how an 
87 individual perceives themselves physically(4) and sufferers have a distorted and 
88 negative view of themselves, feeling anxious and uncomfortable about their 
89 body. Additionally, negative BI can have a serious impact on health and well-
90 being(5).
91 Social media and celebrity attention contribute to pressure to adhere to an 
92 “ideal” body and an obsession with appearance(6, 7). Discontentment with 
93 aspects such as body weight, shape, appearance and skin may contribute 
94 toward an individual having BID(8). Studies have shown patients with negative 
95 BI are more likely to suffer with depression, anxiety and feel suicidal and BID 
96 can impact negatively upon relationships(9) and quality of life (QoL)(10).
97 Various tools have been utilised in healthcare to measure BI including the Body 
98 Image Ideals Questionnaire, the Body Image Scale and the Cash Body Image 
99 Disturbance Questionnaire (BIDQ)(11). There are also condition-specific BI tools 
100 such as the Body Image Scale (BIS) for IBD(12).
101 Both condition-specific symptoms and treatments may contribute to BID in IBD 
102 patients, particularly during periods of active disease rather than remission. 
103 Symptoms can include urgent bowel movements, bloating, excess wind, fatigue, 
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104 skin problems and ulcers. Treatment with steroids can be associated with 
105 weight gain, acne and mood swings(13). Surgeries may also impact upon BI due 
106 to scarring and implementation of a stoma(14) (15). Those suffering with IBD or 
107 BID are at an increased risk of mental health issues(16, 17) ; this could be worse 
108 for patients living with both conditions. Furthermore, most IBD patients are 
109 diagnosed at adolescence(18), when BI is important. Body image is currently not 
110 routinely considered in the management of IBD.
111 No existing or ongoing systematic reviews on BI in IBD have been identified. 
112 However multiple primary studies, mainly cross-sectional in nature assess BI as 
113 an outcome in IBD patients, with disparate results. A systematic review is 
114 therefore warranted to synthesise and clarify the evidence base. 
115
116 The following four questions will be addressed:
117
118 1. What tools are used to measure body image in IBD patients and what are 
119 their components? 
120 2. What is the prevalence and severity of body image dissatisfaction in IBD 
121 patients?
122 3. What factors are associated with body image dissatisfaction in IBD patients? 
123 4. Is there an association between body image dissatisfaction in IBD patients 
124 and quality of life?
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7
125 METHODS
126 This systematic review has been reported according to the Preferred Reporting 
127 Items of Systematic Reviews and Meta-Analysis (PRISMA) guidelines(19). A 
128 protocol was previously registered (PROSPERO (CRD42018060999)) and 
129 submitted for publication and is currently in process(20). A summary of the 
130 methods is reported below. Selection, data extraction and quality assessment 
131 were carried out by two independent reviewers with disagreements resolved 
132 through discussion or third reviewer.
133
134 Search Strategy
135 Bibliographic databases (EMBASE, MEDLINE, PsycINFO, Cochrane 
136 CENTRAL) were searched to April 2018 using combinations of index and text 
137 terms for IBD and BI (see Supplementary table 1 for MEDLINE strategy) 
138 Strategies were adapted for each database and run without date or language 
139 restrictions. Trial registries (Clinicaltrials.gov, EU Clinical Trial Register) were 
140 searched for ongoing trials and reference lists of included studies were 
141 checked. 
142
143 Screening and Selection Criteria
144 Study eligibility was based on the following criteria: 
145 Study design: Any primary study reporting quantitative data. 
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8
146 Population: Patients of any age diagnosed with IBD.  At least 50% of population 
147 must have IBD unless results are reported separately for sub-groups of 
148 individuals with IBD.
149 Tools: Any tool measuring any aspect of BI (including QoL tools that had at 
150 least one BI related domain or question). 
151 Studies were also eligible (for question 2-4) where they reported: any measure 
152 of prevalence/frequency and severity of BID in IBD patients; data on 
153 associations between any factor in IBD patients and BID; or any association 
154 between BI and QoL measures in IBD patients, including associations between 
155 two separate domain measures of the same tool.
156 Exclusion criteria: Case reports, qualitative research and conference abstracts 
157 published three years before the date of the searches.
158 Reasons for exclusion were recorded.
159
160 Data Extraction  
161 A piloted data extraction form was used. Examples of the type of data extracted 
162 are shown below: 
163 Study characteristics: 
164 Study design, aim and setting, inclusion/exclusion criteria, recruitment methods, 
165 follow-up period.
166 Participant characteristics:
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9
167 Number of patients, age, gender, type of IBD, disease severity and activity, 
168 BMI, comorbidities, therapy/surgery.
169 Data for synthesis/analysis:
170 BI measurement tool, components of tools/scales, data on BID (e.g. body image 
171 scores, prevalence, thresholds for determining BID), factors associated with BI 
172 dissatisfaction and strength of association, QoL measures, strength of 
173 association between BID and QoL. 
174
175 Quality Assessment 
176 Quality assessment was based on critical appraisal checklists for both 
177 prevalence and cross-sectional analytical studies from the Joanna Briggs 
178 Institute(21). Studies solely included for question one were not quality assessed 
179 as the objective of this question was to compil  a list of body image tools.
180 Important quality items included sample selection, response rate during 
181 enrolment in the study, clear inclusion criteria and measurement of outcomes in 
182 a valid and reliable way. 
183
184 Analysis
185 A narrative synthesis was carried out separately for each question, with key 
186 findings tabulated. Substantial heterogeneity relating to populations, tools and 
187 settings was apparent in the included studies meaning that meta-analysis was 
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10
188 not appropriate. Consistencies and discrepancies in findings between studies 
189 were noted and discussed in the context of any likely sources of heterogeneity.   
190 Quality assessment findings were used when considering the strength of 
191 evidence for the latter three questions.  
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
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11
207 RESULTS
208 Database searches identified 587 records and 57(14, 22-77) studies were included, 
209 with some studies eligible for multiple questions (see Figure 1 for selection 
210 process and reasons for exclusion). All 57 papers reported using BI tools, 31(14, 
211 22-26, 30, 31, 33-39, 42, 47, 50, 51, 53, 54, 59, 61, 62, 64-66, 68, 70, 72, 73) reported prevalence or 
212 mean/median BI scores, 16(14, 23, 24, 30, 34-36, 47, 54, 59, 61, 62, 64, 66, 68, 72) studies 
213 presented factors associated with BID and 8(14, 22-24, 34, 62, 66, 72) studies reported 
214 correlations between QoL and body image.
215
216
217
218
219
220
221
222
223
224
225
226
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12
227 Question 1: What tools are used to measure body image and what are 
228 their components?
229 Of the 57 studies measuring BI, 51 were cross-sectional whilst the others varied 
230 (case-control(25),prospective cohort(51, 66),case series(39), randomised controlled 
231 trial(65) and non-randomised intervention study(42)). Study populations included 
232 adults and children in settings including outpatients, pre/post-surgery, summer 
233 camps and online registries, from countries across the world. Twenty studies 
234 focused on BI as one of the main outcomes but only six of these studies were 
235 non-surgery based.  
236 Fifteen tools were identified (Table 1). Seven tools were specifically for BI and 
237 eight were QoL tools which included a BI domain or question(s). The most 
238 frequently applied tool specific to BI was the Body Image Questionnaire (BIQ) 
239 which was used in 14 studies. The Body Image Scale (BIS) was used in 5 
240 studies and is the only tool validated in an IBD population. IMPACT-III (or earlier 
241 IMPACT-II) is a validated QoL questionnaire aimed at adolescents and children 
242 with IBD and includes a BI domain. It was used across 18 studies. The 
243 remaining 12 tools were used in only 1-3 studies respectively.
244 None of the tools included had a clear cut-off point for defining BID but offered 
245 an indication of increasing or decreasing likelihood of dissatisfaction. In some 
246 tools, a higher score indicated better BI (BIQ, EORTC, DUX-25). In others, a 
247 higher score indicated increased BID (IMPACT, BIS, RFIPC, IBDSI, Body 
248 Image Self-Consciousness during Intimacy Scale, BIDQ and ASWAP).
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13
249 Tools where items had similar themes were grouped to show general focus of 
250 BI questions and are shown in Table 2.
251
Measurement Tool Type of Tool Intended target 
population
Is tool 
Validated?
Scoring No. of 
Studies 
Tool 
Used In
Body Image Tools
ASWAP Body image Initially used in 
scleroderma 
patients
Yes but not in 
IBD patients
15 items rated on 7-point 
scale. Questions 
corresponding to items 
4–11 were reverse 
scored such that higher 
scores reflect greater 
dissatisfaction
1
Askevold’s Body Image Test Body image Unclear Unclear Unclear 2
Body Image and Self-
Consciousness During 
Intimacy
Scale
Body image and sexual 
self-consciousness 
Women No 0-75, higher scores 
poorer body image
1
 BIA/BIA-P Body image Adults, no specific 
clinical population
Unclear Based on body image 
silhouettes ranging in 
size. Score=difference 
between current body 
size and ideal body size. 
1
BIQ Body image Originally 
caesarean or 
appendectomy 
patients, now IBD 
No 5-20, higher score better 
body image
14
Table 1.  Tools identified and used across included studies
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14
patients 
BIS Body image Cancer patients Yes 0-30, lower score better 
body image
5
Cash Body Image 
Disturbance Questionnaire
Body image Range of clinical 
groups
Yes but not in 
IBD patients
7-35, higher score poorer 
body image
2
Quality of Life Tools with a Body Image Component
DUX-25 Quality of daily 
functioning. (1 of 4 
domains relate to body 
image)
School age 
children
No Higher scores, better 
QoL
1
EORTC-QLQ-CR38 Quality of Life 
questionnaire. (3 of 38 
items relate to body 
image)
Cancer patients Yes but not in 
IBD patients
38 items with 4 category 
responses. Functional 
scales: higher score 
higher functioning. 
Symptoms scales: higher 
score higher level of 
symptoms.
1
EORTC-QLQ-CR29 Quality of Life 
questionnaire. (3 of 29 
items relate to body 
image)
Cancer patients Yes but not in 
IBD patients 
29 items with 4 category 
responses.
Functional scales: higher 
score higher functioning. 
Symptoms scales: higher 
score higher level of 
symptoms.
1
IMPACT-III or IMPACT II Health-related quality of 
life. (3 of 35 items relate 
to body image)
Children and 
adolescents with 
IBD
Yes 35-175, higher scores 
better QoL
18
Inflammatory Bowel Disease 
Stress Index
Assessing the extent to 
which IBD has caused 
alterations in lifestyle. (1 
of 10 items relate to body 
IBD patients Unclear 8 scales with a score of 
0-3 (no impact-a great 
deal of impact).
1
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252
253
254
255
256
257
258
image)
RFIPC Quality of life 
questionnaire. (1 item of 
25 relate to body image)
IBD patients Yes 0-100, higher score 
poorer QoL
3
Stoma Quality of Life Scale Stoma-related. (5 items 
of 19 relate to body 
image and sexuality).
Stoma patients Yes (in ostomy 
patients)
5 scales, 19 questions. 
Each scored 1-5 (Never-
always). Average scores 
for each scale calculated.
3
The Karolinska 
Psychodynamic Profile
Assessment of stable 
modes of mental 
functioning and character 
traits (1 subscale and 3 
of 18 items relate to body 
image.)
No specific clinical 
population 
Yes Each subscale is graded 
from 1-3 (Most normal-
least normal).
2
Abbreviations:  ASWAP: Adapted Satisfaction with Appearance scale;  BI/BIA-P:  Body Image Assessment/Body Image Assessment-
Preadolescent; BIQ: Body Image Questionnaire; BIS: Body Image Scale; DUX-25:  Dutch Children’s AZL/TNO Quality of Life 
Questionnaire; EORT-QLQ-CR38/EORT-QLQ-CR29:  European Organisation for Research and Treatment of Cancer (EORTC) Quality 
of Life questionnaire for Colorectal Cancer; IMPACT-II/IMPACT-III:A measure of health-related quality of life in paediatric 
inflammatory bowel disease; RFIPC: Rating Form of IBD Patient Concerns.
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16
Body Image Tool Components
Satisfaction 
with 
appearanc
e
Attractive
ness
Socialisi
ng/Work
Avoidance 
of people 
or tasks
Feeling 
feminine/ 
masculin
e
Effect of 
disease 
on body
Scar 
satisfacti
on
Satisfaction 
with body 
both naked 
and 
dressed
Distressing thoughts
BIS      
BIQ      
CBIDQ     
ASWAP     
N.B. Similar components of tools were grouped into themes shown above. BIS=Body Image Scale. BIQ=Body Image Questionnaire. 
Table 2.  Body image tools with similar questions grouped into overarching themes
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CBDIQ=Cash Body Image Disturbance Questionnaire. ASWAP=Adapted Satisfaction with Appearance Scale.  Askevold’s Body Image Test 
(no information in paper or online), Body Image and Self-consciousness during Intimacy Scale (too specific) and the Body Image 
Assessment (based on figural drawing scales) were not included.
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260 What is the prevalence of body image dissatisfaction in IBD patients?
261 Thirty-one studies including a total of 3,634 patients reported on prevalence or 
262 severity of BID (see Table 3 for study characteristics). Seventeen studies(14, 22, 
263 23, 25, 30, 31, 38, 42, 53, 54, 59, 61, 62, 66, 70, 72, 73) included both ulcerative colitis (UC) and 
264 Crohn’s disease (CD) patients. Ages ranged from 2-71 and eighteen studies(22, 
265 30, 38, 40-42, 51-53, 58, 60-63, 70, 71, 73, 76) included only children/adolescents. Fourteen 
266 studies(24-26, 33-37, 39, 47, 50, 64, 65, 68) included surgery patients and one study 
267 included only females(72). 
268 Only three studies reported prevalence. Brown (2015)(26) found that 21-34% UC 
269 patients reported negative impacts on BI using BIQ. McDermott (2015)(14) found 
270 that 87% patients reported some form of concern about an aspect of their BI 
271 using the Cash Body Image Disturbance Questionnaire. Muller (2010)(59) 
272 reported that 66.8% IBD patients stated they had impaired BI based on a 
273 researcher devised questionnaire. The other 28 studies reported mean/median 
274 BI scores based on a range of tools. 
275 In studies with populations undergoing surgery it was found that there was no 
276 significant difference in BI scores (using the BIQ) after laparoscopic or 
277 open/conventional surgery in IBD patients(33-35, 64, 78). Only one study found BI 
278 scores to be significantly improved after laparoscopic surgery compared to 
279 conventional surgery in CD(36). 
280 BI was included as an outcome across 31 studies. All but one study compared 
281 results within the included IBD population e.g. UC vs CD, surgery vs no surgery, 
282 males vs females. Bel (2015) found that women with IBD with disease in 
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283 remission scored comparably to women in a healthy population. One 
284 longitudinal study by Saha (2015)(66) measured scores over two years and 
285 found that BI did not change despite improvements in symptoms. 
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
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Study Design Population Country No. 
patients
No. 
UC/CD/Other
Body Image 
Tool
Outcomes Body Image 
Prevalence/Score
Beld et al 
(2010)
Cross 
sectional 
UC or FAP undergone restorative proctocolectomy  
IPAA Jan 92 to Oct 08
Netherla
nds
26 UC (16) FAP 
(10)
BIQ Mean body image 
scores (SD)
Males 16.3 (3.1) 
Females 13.5 (4.1)
Brown et 
al (2015)
Cross 
sectional 
Patients with UC who had colectomy within the 
past 10 years, data collected from Nov 2010 to 
July 2011. 
Canada, 
Australia, 
UK
351 All UC BIQ Median body image 
scores (IQR)
Prevalence of “quite a 
bit” or “extreme” 
negative impacts on 
body image as a 
result of colectomy. 
Males 8 (IQR 6-11) 
Females 11 (IQR 8-
14) 
Age group >50 years 
8 (IQR 6-11) 
Age group <50 years 
10 (IQR 7-13). 
21-34% reported 
negative impacts on 
body image.
Dunker et 
al (1998)
Cross 
sectional 
CD patients undergoing open or laparoscopic 
resection at Leiden university medical centre
Netherla
nds
34 All CD BIQ Mean body image 
scores
Open 16.4 (10-20) 
Laparoscopic 18 (13-
20) 
(SD not reported)
Table 3. Study characteristics of papers included for questions two, three and four. 
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Study Design Population Country No. 
patients
No. 
UC/CD/Other
Body Image 
Tool
Outcomes Body Image 
Prevalence/Score
Dunker et 
al (2001)
Cross 
sectional 
matched 
compariso
n
UC patients who underwent laparoscopic assisted 
IPAA and matched conventional IPAA patients. 
Netherla
nds
32 UC (28) FAP 
(4)
BIQ Mean body image 
scores (SD)
Laparoscopic 19 (1.3) 
Conventional 17.9  
(SD not reported)
Eshuis et 
al (2008)
Repeated 
cross 
sectional
Patients who underwent ileocolic resection for 
Crohn’s disease from 1995 until 1998 two centres.
Netherla
nds
71 
(medical 
file 
analysis) 
61 
(returned 
question
naires)
All CD BIQ Mean body image 
scores (range)
Open 15.63 (6-20) 
Laparoscopic 16.3 (7-
20) 
(SD not reported)
Eshuis et 
al (2010)
Repeated 
cross 
sectional
CD patients who had ileocolic resections between  
September 1999 and November 2003.
Netherla
nds
55 All CD BIQ Median body image 
scores (IQR)
Open 18.0 (IQR 16-
19) Laparoscopic 
19.0 (IQR 17-20)
Table 3. Study characteristics of papers included for questions two, three and four. 
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Study Design Population Country No. 
patients
No. 
UC/CD/Other
Body Image 
Tool
Outcomes Body Image 
Prevalence/Score
Giudici et 
al (2017)
Case 
series 
(Abstract 
only)
December 2014-December 2015. Consecutive 
patients undergoing laparoscopic proctectomy for 
ulcerative colitis.
Italy 10 All UC Self-designed 
body image 
questionnaire
Mean body image 
score
59 (SD not reported) 
Kjaer et al 
(2014)
Cross 
sectional
Adult patients treated with laparoscopy-assisted or 
open IPAA at Odense University Hospital during 
the period between October 2008 and March 
2012.
Denmark 50 UC (44) FAP 
(4) Other (2)
BIQ Median body image 
scores (range)
Laparoscopic 8 (5-18) 
Open 9.5 (5-20)
Polle et al 
(2007)
Repeated 
cross 
sectional
Patients eligible for an elective proctocolectomy 
with IPAA for UC or FAP were included in a 
randomized trial
Netherla
nds
53 UC (34) FAP 
(19)
BIQ Mean body image 
scores (limited data)
Women open group 
15
Laparoscopic group: 
18
(SD not reported)
Table 3. Study characteristics of papers included for questions two, three and four. 
Page 23 of 69
https://mc.manuscriptcentral.com/bmjgast
BMJ Open Gastroenterology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
23
Study Design Population Country No. 
patients
No. 
UC/CD/Other
Body Image 
Tool
Outcomes Body Image 
Prevalence/Score
Ponsioen 
et al 
(2017)
Randomise
d 
controlled 
trial
Eligible patients aged 18–80 years, had active 
Crohn’s disease of the terminal ileum, and had not 
responded to at least 3 months of conventional 
therapy with glucocorticosteroids, thiopurines, or 
methotrexate. Patients with diseased terminal
ileum longer than 40 cm or abdominal abscesses 
were excluded.
Netherla
nds and 
UK
70 
Infliximab 
group 73 
Laparosc
opic 
ileocaeca
l 
resection
All CD BIQ Mean body image 
scores (only given for 
resection group)
Resection group:
Baseline 16. 
Endpoint 17.8.
(SD not reported)
Scarpa et 
al (2009)
Prospectiv
e case 
series
Patients admitted for intestinal surgery for CD May 
06 - July 08
Italy 47 All CD BIQ Median body image 
score (IQR)
5 (5-8)
Voermans 
et al 
(2010)
Prospectiv
e case 
series
A consecutive series of patients who had an 
indication for a laparoscopic ileocolic resection 
were invited to participate. CD patients. 
Netherla
nds
10 All CD BIQ Median body image 
scores
Before surgery 17.0 
After surgery  19.0 
Bengtsso
n et al 
(2011)
Case-
control
Patients with preoperative diagnosis of UC or CD 
who underwent IPAA
Sweden 101
(72 
controls, 
Controls; UC 
(60) CD (0) 
Study group; 
BIS Median body image 
scores.
Study group: Males 
6.5 Females 10. 
Control group Males 
Table 3. Study characteristics of papers included for questions two, three and four. 
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Study Design Population Country No. 
patients
No. 
UC/CD/Other
Body Image 
Tool
Outcomes Body Image 
Prevalence/Score
29 study 
group)
UC (25) CD 
(4) 
1 Females 3
Trindade 
et al 
(2017)
Cross 
sectional
Female participants with ages between 18 and 40 
years old who had not undergone IBD-related 
surgery
Portugal 96 UC (58) CD 
(38)
BIS Mean body image 
score (SD)
10.10 (7.73)
(SD not reported)
Vlahou et 
al (2008)
Cross 
sectional
Adolescents with IBD who attended clinics at two 
separate hospitals and a camp for children with 
IBD
USA 44 Breakdown not 
reported
BSQ (modified 
version of BIQ) 
and BIA-P 
Mean body image 
scores (SD)
BSQ: Males 36.45 
(4.88) Females 33.52 
(7.77). 
BIA-P: Males  0.41 
(0.85) Females 0.77 
(0.92)
Grootenh
uis (2009)
Non-
randomise
d 
controlled 
Adolescents with IBD who were under medical 
care at Emma Children's Hospital AMC and 
members of Crohn's and colitis association 
Netherlands
Netherla
nds
18 
controls; 
22 
interventi
Controls CD 
(11) UC (4) 
IBDU (3). 
Intervention 
DUX-25 Mean body image 
domain scores (SD)
Intervention: baseline 
55.4 (18.6) post 
intervention 68.9 
(17.7) Control: 
Table 3. Study characteristics of papers included for questions two, three and four. 
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Study Design Population Country No. 
patients
No. 
UC/CD/Other
Body Image 
Tool
Outcomes Body Image 
Prevalence/Score
study on CD (17) UC 
(5) IBDU (0)
baseline 60.0 (17.4) 
post intervention 59.0 
(20.1)
Bel et al 
(2015)
Cross 
sectional 
with 
controls 
18-70 UC or CD Netherla
nds
287 
(197 
healthy 
controls)
UC (132) CD 
(155)
EORTC-QLQ-
CR38
Mean body image 
domain scores (SD)
Active: Males 5.61 
(2.31) Females 6.2 
(2.78). Remission: 
Males 3.82 (1.33)
Females 4.58 (1.68)
Shepanksi 
(2009)
Before and 
after study
Children attending Camp Guts and Glory in 
Pennsylvania 
USA 61 CD:UC (2:1) IMPACT II Mean body image 
domain scores (SD, 
for before and after 
camp)
By age; 
Age 9-10: pre  14.6 
(4.1). Post 16.4 (3.7). 
Age 11-12: Pre 11.4 
(4.9). Post 13.2 (5.0).
Age 13-14:Pre 12.9 
(5.2). Post 13.8 (5.9). 
Age 15-16: Pre 12.3 
Table 3. Study characteristics of papers included for questions two, three and four. 
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Study Design Population Country No. 
patients
No. 
UC/CD/Other
Body Image 
Tool
Outcomes Body Image 
Prevalence/Score
(5.0). Post 11.2 (5.4)
Abdovic 
et al 
(2013)
Cross 
sectional 
validation 
study
Children aged nine years or older with confirmed 
diagnosis of IBD for more than six months from 
inpatient and outpatient clinics at particular 
centres.
Croatia 104 UC (30) CD 
(74)
IMPACT III Mean body image 
domain score (SD). 
12.03 (1.96)
Chouliara
s et al 
(2017)
Cross 
sectional 
UC and CD patients hospitalized or followed in 
outpatient clinic in Athens 
Greece 99 UC (37) CD 
(62)
IMPACT III Mean body image 
domain scores (SD)
Overall 71.5 (17.9) 
UC 67.3 (22.4) CD 
72.6 (19.3)
No significant 
relationship between 
body image and 
assessed disease 
characteristics or 
Table 3. Study characteristics of papers included for questions two, three and four. 
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Study Design Population Country No. 
patients
No. 
UC/CD/Other
Body Image 
Tool
Outcomes Body Image 
Prevalence/Score
prescribed 
medications. 
Gallo et al 
(2014)
Cross 
sectional 
Children between the ages of 8 and 18 years, who 
had been diagnosed with IBD at least 6 months 
before, and were being followed at the Pediatric 
Gastroenterology Service of the Hospital Italiano 
de Buenos Aires, Argentina, or at the private office 
of one of the co-authors (M.O.) and one of their 
parents.
Argentina 27 UC (17) CD 
(9)
IMPACT III Mean body image 
domain score (SD)
76.54 (16.06)
Lee et al 
(2015)
Prospectiv
e 
observatio
nal study 
Children and young adults less than 22 years of 
age started on EN or anti-TNF therapy for active 
CD at Hospital for Sick Children Toronto and 
Children's Hospital Philadelphia. 
Canada 
and USA
90 All CD IMPACT III Median body image 
domain scores 
(range)
Baseline  PEN 71 
(54-75) EEN 58 (58-
75) TNf 67 (50-83)
Table 3. Study characteristics of papers included for questions two, three and four. 
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Study Design Population Country No. 
patients
No. 
UC/CD/Other
Body Image 
Tool
Outcomes Body Image 
Prevalence/Score
Mason et 
al (2015)
Prospectiv
e 
observatio
nal study 
Adolescents >10 years old with confirmed 
diagnosis of IBD attending gastroenterology clinic 
at Royal Hospital for Sick Children, Glasgow
Scotland 63 UC/IBDU (18) 
CD (45)
IMPACT III Mean body image 
domain score
7 (SD not reported)
Ogden et 
al (2011)
Cross 
sectional 
validation 
study
Unclear - children with IBD UK 97 UC (12) CD 
(64) IBDU (21)
IMPACT III Mean body image 
domain score
63.5 (95% CI 56.5 - 
70.6)
(SD not reported)
Perrin et 
al (2008)
Cross 
sectional 
Children aged 8-17 years diagnosed with UC or 
CD 6 mnths before the study followed at 1 of 6 
paediatric gastroenterology centres. No other 
chronic conditions.
USA 220 UC (59) CD 
(161)
IMPACT III Mean body image 
domain scores (SD)
68.1 (19.6) 
UC 68.6 (20.8)
CD 67.9 (19.2)
Table 3. Study characteristics of papers included for questions two, three and four. 
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Study Design Population Country No. 
patients
No. 
UC/CD/Other
Body Image 
Tool
Outcomes Body Image 
Prevalence/Score
McDermot
t et al 
(2015)
Cross 
sectional 
Patients with histologically confirmed IBD 
attending ambulatory clinics in 1 of 2 medical 
centres between July 2011 and November 2012
Ireland 330 UC (145) CD 
(194)
Modified BIS 
and Cash 
Body Image 
Scale 
(qualitative 
only)
Median body image 
score (range)
Prevalence
6 (0-27)
13% patients reported 
no concerns about 
any aspect of body 
image
Saha et al 
(2015)
Prospectiv
e 
observatio
nal study
Patients with UC, CD or IBDU aged 18 and above 
enrolled in the Ocean State Crohn's and Colitis 
Area Registry (OSCCAR) with a minimum of 2 
years of follow-up
USA 274 CD (145) 
UC/IBDU 
(129)
 ASWAP Mean body image 
scores (SD)
Baseline: Females 
30.1 (14.4) Males 
21.2 (8.4) Year 1: 
Females 28.2 (14.1) 
Males 24.5 (12.5) 
Year 2: Females 28.8 
(13.2) Males 24.1 
(13.5) 
Table 3. Study characteristics of papers included for questions two, three and four. 
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Study Design Population Country No. 
patients
No. 
UC/CD/Other
Body Image 
Tool
Outcomes Body Image 
Prevalence/Score
Muller et 
al (2010)
Cross 
sectional 
IBD patients aged 18-50 from a database of IBD 
patients maintained by the Southern Adelaide IBD 
Service
Australia 217 UC (85) CD 
(127) IBDU (5)
No specific 
tool  – range of 
questions 
regarding body 
image and 
impact of IBD 
on this
Prevalence (%) of 
body image 
dissatisfaction 
66.8% of patients 
reported impaired 
body image
de Rooy 
et al 
(2001)
Cross 
sectional 
Outpatients of the Inflammatory Bowel Disease 
Center, Mount Sinai Hospital. Subjects were a 
convenience sample waiting for a regularly 
scheduled physician appointment.
USA 241 UC (121) CD 
(120)
RFIPC “Feelings about body” 
question mean score 
(SD)
42.84 (33.97) 
Maunder 
et al 
(1999)
Retrospecti
ve analysis
Patients with IBD who had completed the RFIPC 
and a survey of demographic and disease-related 
variables in one of three previous studies 
Unclear 343 UC (186) CD 
(157)
RFIPC “Feelings about body” 
question mean scores
Female 52.13 (34.8) 
Male 38.16 (33.83)
Kuruvilla 
et al 
Cross-
sectional 
Consecutive patients who had undergone IPAA or 
a permanent ileostomy for ulcerative colitis by a 
USA 59
  
All UC. IPAA 
(35); TPC (24).
Stoma Quality 
of Life Scale
Mean (SD) and 
median (range) body 
IPAA; Mean 93.1 
(9.7). Median 100. 
Table 3. Study characteristics of papers included for questions two, three and four. 
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Study Design Population Country No. 
patients
No. 
UC/CD/Other
Body Image 
Tool
Outcomes Body Image 
Prevalence/Score
(2012) (Abstract 
only)
single surgeon, presenting for their annual follow-
up visit from July through September 2011, were 
offered participation in the study. A randomly 
chosen group of subjects who did not have 
scheduled appointments during the study period 
were sent a letter inviting them to participate in the 
study.
image/sexuality 
domain scores.
(65-100). TPC: Mean 
76.4 (14.6) Median 80 
(50-100).
Abbreviations: UC: Ulcerative Colitis; CD: Crohn’s disease;  IBD: Inflammatory bowel disease; IBDU: Inflammatory bowel disease unclassified; FAP: Familial adenomatous polyposis; IPAA: 
ileal pouch-anal anastomosis; TPC: Total proctocolectomy; PEN: Partial Enteral Nutrition; EEN: Exclusive Enteral Nutrition; TNF; Tumour Necrosis Factor; TNF: Tumour necrosis factor; IQR: 
Interquartile range; SD; Standard deviation; ASWAP: Adapted Satisfaction with Appearance scale;  BI/BIA-P:  Body Image Assessment/Body Image Assessment-Preadolescent; BIQ: Body 
Image Questionnaire; BIS: Body Image Scale; DUX-25:  Dutch Children’s AZL/TNO Quality of Life Questionnaire; EORT-QLQ-CR38/EORT-QLQ-CR29:  European Organisation for 
Research and Treatment of Cancer (EORTC) Quality of Life questionnaire for Colorectal Cancer; IMPACT-II/IMPACT-III:A measure of health-related quality of life in paediatric inflammatory 
bowel disease; RFIPC: Rating Form of IBD Patient Concerns; BSQ: Body Satisfaction Questionnaire. 
302
303
304
Table 3. Study characteristics of papers included for questions two, three and four. 
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305 What factors are associated with body image dissatisfaction in IBD 
306 patients?
307 Sixteen studies(14, 23, 24, 30, 34-36, 47, 54, 59, 61, 62, 64, 66, 68, 72) totalling 2333 IBD patients 
308 reported the association between various factors and BID (see Table 4). 
309 Factors included those related to demographics as well as disease and 
310 treatment-related characteristics. Ten studies(14, 24, 34-36, 47, 64, 66, 68, 72) utilised a 
311 specific BI tool and six(34-36, 47, 64, 68) focused on comparative surgery techniques. 
312 Three studies(30, 61, 62) included a paediatric population; the remaining studies 
313 included adults. BI was one of the main outcomes in most of these studies and 
314 the study by Saha (2015)(66) was the first longitudinal follow up of BID in IBD 
315 according to the authors.
316 In 6/10 studies(14, 23, 54, 59, 64, 66) female gender was found to be significantly 
317 associated with increased BID. One study(59) reported the odds of BID was over 
318 3 times more in females than males (p=0.001), with strong associations 
319 reported in the other five studies. Increased disease activity was found to have 
320 a significant but moderate positive association in 7/9 studies(14, 23, 34, 62, 66, 68, 72)
321 Other factors found to be significantly associated with increased BID included 
322 steroid use(14, 61, 66, 72), age(14, 23), increased BMI(14, 72), smoking(14) and 
323 fatigue(23)(Table 4). Saha (2015)(66) also found a significant association between 
324 extraintestinal manifestations (EIM) and increased BID, but were the only study 
325 to assess this. Laparoscopic surgery was found to be associated with improved 
326 body image in 2/6 studies(36, 68). Ileal pouch-anal anastomosis (IPAA) seemed to 
327 result in patients being satisfied with their body image in two studies(24, 26) but 
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328 they lacked a comparative surgery group. One study(50) compared IPAA and 
329 ileostomy and found better body image scores in the IPAA group. No significant 
330 associations were found between disease sub-type and increased BID. 
331 Is there an association between body image dissatisfaction and quality of 
332 life in IBD patients?
333 Eight studies(14, 22-24, 34, 62, 66, 72) explored a potential association between BID 
334 and QoL across a total of 1371 patients, with seven presenting a significant 
335 association. Three studies(22, 24, 62) (Table 4) focused on younger populations 
336 with the rest including adults only. The majority of studies included populations 
337 with both UC and CD whilst two (24, 34) included only one subtype. 
338 Statistically significant weak to moderately strong correlations were present in 
339 five studies(22, 23, 34, 62, 72) ranging from r = 0.34 to r = 0.67. Furthermore, 
340 McDermott(2015)(14) found that when using the BI scale there was a significant 
341 difference in scores between those with good or poor QoL. Trindade(2017)(72) 
342 found that BI was positively correlated with psychological and physical QoL. 
343 Saha(2015)(66) found that a one unit increase in the total ASWAP score 
344 (indicating poorer body image) was associated with a 0.62 decrease in QoL 
345 score (p<0.0001).
346 Various QoL tools (See Table 1) were used across studies with some using 
347 more than one. Four of these questionnaires used (IMPACT II and III, GIQLI 
348 and WHOQOL-BREF) contain a question or domain on BI, potentially making 
349 them more likely to correlate with BI questionnaires. 
350
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354
Factor Study
A
bdovic 
2013
B
el 2015
B
eld 2010
C
houliaras 
2017
D
unker 
1998
E
shuis 
2008
E
shuis
2010
K
jaer 2014
M
aunder 
1999
M
cD
erm
ott 
2015
M
uller 
2010
O
gden 
2011
P
errin 
2008
P
olle 2007
S
aha 2015
S
carpa 
2009
Trindade 
2017
Female 
gender
r= -
0.1
8*
Differe
nce in 
means 
p=0.0
8 
Differe
nce in 
means 
p>0.10
Differe
nce in 
scores 
p=0.18
No 
signific
ant 
associ
ation
Female
s 
signific
antly 
worse 
scores*
p<0.0
01*
Differe
nce in 
proport
ions 
p=0.00
07
Signific
antly 
worse 
scores 
in open 
surgery 
group 
p=0.00
4*
p<0.000
1*
Table 4. Most common factors found to be significantly associated with impaired body image in IBD as reported in each study, including 
associations between reduced body image and reduced QoL.
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Factor Study
A
bdovic 
2013
B
el 2015
B
eld 2010
C
houliaras 
2017
D
unker 
1998
E
shuis 
2008
E
shuis
2010
K
jaer 2014
M
aunder 
1999
M
cD
erm
ott 
2015
M
uller 
2010
O
gden 
2011
P
errin 
2008
P
olle 2007
S
aha 2015
S
carpa 
2009
Trindade 
2017
Higher 
disease/
sympto
m 
activity
r= 
0.3
8*
No 
signific
ant 
associ
ation
r=0.5* p<0.0
01*
p= 
0.5
0
p= 
0.00
3*
In UC 
p=0.006
*
In CD 
p=0.003
*
Multiple 
regressi
on 
β=0.426 
p=0.006
*
Active 
diseas
e 
r=0.18
Sympt
oms 
r=0.40
*
Fatigue r= 
0.5
5*
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Factor Study
A
bdovic 
2013
B
el 2015
B
eld 2010
C
houliaras 
2017
D
unker 
1998
E
shuis 
2008
E
shuis
2010
K
jaer 2014
M
aunder 
1999
M
cD
erm
ott 
2015
M
uller 
2010
O
gden 
2011
P
errin 
2008
P
olle 2007
S
aha 2015
S
carpa 
2009
Trindade 
2017
Disease 
Subtype
No 
signific
ant 
associ
ation
p=0.6
3
Differe
nce in 
proport
ions p= 
0.094
p=0.
05
No 
associa
tion 
found
Age r= - 
0.1
8*
No 
signific
ant 
associ
ation
Youn
ger 
age 
p<0.0
01*
r= -
0.06
Steroids No 
signific
ant 
associ
ation
No 
signific
ant 
associ
ation
p= 
0.03*
p= 
0.0
5*
p=0.02* r= 
0.22*
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Factor Study
A
bdovic 
2013
B
el 2015
B
eld 2010
C
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D
unker 
1998
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shuis 
2008
E
shuis
2010
K
jaer 2014
M
aunder 
1999
M
cD
erm
ott 
2015
M
uller 
2010
O
gden 
2011
P
errin 
2008
P
olle 2007
S
aha 2015
S
carpa 
2009
Trindade 
2017
Smokin
g
p=0.0
01*
Open/
convent
ional 
surgery
Differe
nce in 
scores 
p=0.2
Differe
nce in 
means 
p=0.51
Differe
nce in 
media
n 
p=0.03
*
Differe
nce in 
media
n 
p=0.1
7
No 
signific
ant 
differen
ces
Multiple 
regressi
on (for 
laparos
copic 
approac
h) 
β=0.331 
p=0.036
*
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Factor Study
A
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2013
B
el 2015
B
eld 2010
C
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D
unker 
1998
E
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2008
E
shuis
2010
K
jaer 2014
M
aunder 
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M
cD
erm
ott 
2015
M
uller 
2010
O
gden 
2011
P
errin 
2008
P
olle 2007
S
aha 2015
S
carpa 
2009
Trindade 
2017
Increase
d BMI
Fema
les 
only 
p<0.0
01*
No 
significa
nt 
associa
tion
r= 
0.25*
Page 40 of 69
https://mc.manuscriptcentral.com/bmjgast
BMJ Open Gastroenterology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
40
Factor Study
A
bdovic 
2013
B
el 2015
B
eld 2010
C
houliaras 
2017
D
unker 
1998
E
shuis 
2008
E
shuis
2010
K
jaer 2014
M
aunder 
1999
M
cD
erm
ott 
2015
M
uller 
2010
O
gden 
2011
P
errin 
2008
P
olle 2007
S
aha 2015
S
carpa 
2009
Trindade 
2017
Impaire
d QoL
r= 
0.5
2*
r= 
0.6
7*
r<0.41 r=0.5* p<0.0
01*
r= 
0.51
*
One 
unit 
increas
e 
ASWAP 
score 
associa
ted with 
a 0.62 
decreas
e in 
IBDQ 
(p<0.00
01).*
Psych
ol. 
QoL 
r=0.56
*
Physic
al QoL 
r=0.50
*
*Significant association found. 
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Factor Study
A
bdovic 
2013
B
el 2015
B
eld 2010
C
houliaras 
2017
D
unker 
1998
E
shuis 
2008
E
shuis
2010
K
jaer 2014
M
aunder 
1999
M
cD
erm
ott 
2015
M
uller 
2010
O
gden 
2011
P
errin 
2008
P
olle 2007
S
aha 2015
S
carpa 
2009
Trindade 
2017
N.B: With some tools, higher scores indicate better body image/QoL and in others higher scores indicate worse body 
image/QoL. This may result in both positive and negative correlation coefficients. Where applicable, signs have been flipped for 
ease of interpretation to clearly show the positive correlation between body image and quality of life.
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356 Risk of Bias
357 The 31 studies relevant for questions 2-4 were assessed using criteria from the 
358 Joanna Briggs Institute critical appraisal tools for analytical cross-sectional and 
359 prevalence designs (Supplementary Table 2). Only cross-sectional data was 
360 relevant for the review. Poor reporting of quality criteria in many studies made 
361 quality assessment difficult. Where criteria were reported, the overall quality 
362 was variable. Most studies had some areas of low and higher quality. Only one 
363 study, McDermott (2015)(14), was able to demonstrate adequate response rates, 
364 validated outcome measurement tools and adjustment for confounders. 
365 However, Chouliaras (2017)(30), Trindade (2017)(72), Lee (2015)(51) and Bel 
366 (2015)(23) adjusted for confounders and used validated outcome measurement 
367 tools but lacked adequate response rates. 
368 Twenty studies (64.5%) used an appropriate sample frame with acquisition of 
369 patients from outpatient settings, IBD registries or healthcare records. Eighteen 
370 studies (58.1%) clearly reported inclusion criteria applied when recruiting 
371 participants. Only twelve studies (38.7%) had response rates >75%. Fifteen 
372 studies (48.4%) used a tool which had been validated using factor analysis and 
373 internal consistency analysis to measure BI. The others used non-validated 
374 tools. Twelve studies(14, 35, 50, 51, 59, 65, 66, 73) adjusted for potential confounders 
375 such as age, gender, BMI and previous surgery often using multiple regression 
376 models. Several studies reported limited demographic data. It should also be 
377 noted that sample sizes of many of the studies were small and confidence 
378 intervals were mostly not presented. 
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379 DISCUSSION
380
381 Summary of Findings
382 Overall, fifteen different tools were used across 57 studies to measure BI in IBD 
383 patients. These included QoL tools incorporating BI questions or domains, BI 
384 tools and other adapted questionnaires. None offer a defining threshold for 
385 presence or absenc  of BID, which is not commonly considered as a specific 
386 psychological disorder unlike body dysmorphia. 
387 It remains unclear whether IBD patients suffer with BID more so than the 
388 general population as most studies reported mean values with no reference to 
389 healthy population values. Three studies estimated a prevalence of a negative 
390 BI based on one question and this varied between 21 and 81%. This wide 
391 variation likely reflects the differences in tools and study characteristics. All 
392 three studies were based on self-report questionnaires with a wide age range 
393 and registry or hospital-based population. 
394 Certain factors including female gender, disease activity and steroid use were 
395 consistently found to be significantly associated with increased BID in IBD 
396 patients. There was also a significant association between increasing BID and 
397 decreasing QoL reported in eight studies. These findings are consistent with a 
398 previous narrative review(79) assessing BID and sexual functioning in IBD 
399 patients.
400
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401 Strengths and Weaknesses of the Review
402 This is the first systematic review assessing BID in an IBD population, and a 
403 robust methodology was employed to ensure that bias and errors were 
404 minimised. A sensitive search strategy means that it is unlikely that relevant 
405 studies were missed and over 50 studies have contributed to the evidence base 
406 in an area previously unexplored by a systematic review. 
407 The review has some limitations. Some of the extracted data is based on 
408 abstracts only where full texts could not be obtained from the authors. This will 
409 have resulted in some missing information.
410 Furthermore, qualitative studies were not included as this was considered 
411 beyond the scope of this review. It’s likely that there are qualitative studies 
412 which could offer a deeper insight into perception of BI in IBD patients. 
413
414 Strengths and Weaknesses of the Evidence
415 There are some weaknesses within the included evidence. All studies had some 
416 areas of high risk of bias or had poorly reported methodological criteria thus 
417 hampering quality assessment. Some studies had very low response rates 
418 leading to possible under-representation of certain groups. Few studies 
419 adjusted for confounders which could have resulted in overestimates of 
420 associations. 
421 A further issue is the lack of healthy control groups. Although it appears that 
422 IBD patients are concerned about BI, it is difficult to determine whether they are 
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423 affected more than the general population. However, it has been found that 
424 children and adolescents with chronic illnesses such as asthma, cystic fibrosis 
425 and diabetes do have increased BID compared to healthy peers(80). 
426 Non-validated tools were often used for measuring BI and the reliability and 
427 validity of findings based on these is therefore unknown. There is also still little 
428 known about potential changes in BI perception over time. 
429
430 Findings in Context
431 This review is consistent with findings from the narrative review by Jedel 
432 (2015)(79)which found that BI could potentially be a problem in IBD patients. 
433 Whilst surgery has been found to be an important contributing factor in BID in 
434 other research (81), it is unclear how it impacts upon IBD patients. An association 
435 between BID and poorer QoL has been highlighted in both.
436 Females and adolescents are more likely to be concerned with BI and to suffer 
437 with BID compared with males and older people(82-87). Whilst we found 
438 inconsistent results surrounding age, IBD is often diagnosed in adolescence 
439 when BID could be more of a concern.  
440 In oncology, BI is more widely researched. One study suggested gynaecologic 
441 cancer patients suffered with BID which predicted emotional well-being(88). 
442 Another study with advanced cancer patients suggested BID was associated 
443 with depression, anxiety and fatigue(89). Qualitative research in pregnancy(90) 
444 and systematic lupus(91) suggests BI can affect medication compliance and that 
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445 patients would like more support around dealing with BI issues. This could also 
446 be true for IBD patients. 
447 Finally, a previous systematic review found that children with chronic conditions 
448 were more likely to be dissatisfied with their body than healthy peers(92). 
449 Although IBD patients were not included, patients with similar chronic diseases 
450 like diabetes, cancer, asthma and scoliosis were, suggesting IBD patients could 
451 be similarly affected.
452
453 Implications 
454 This evidence identified in this review suggests an association between BID and 
455 poorer QoL as well as finding factors influencing BI in IBD patients. There were 
456 however limitations to the evidence in terms of methodological quality and/or 
457 reporting. Also, results were difficult to compare across studies. More 
458 promisingly, BI is becoming an increasingly assessed outcome, highlighting the 
459 need for continued research in this area. 
460 Current research suggests that age, gender, medication and disease activity in 
461 IBD may impact upon BI. These could be taken into account by clinicians and 
462 patients by altering therapy or targeting comorbidities which could have a 
463 beneficial effect on BID. Interventions to improve BI could be incorporated into 
464 treatment strategies, which may in turn help to improve QoL. A recent 
465 systematic review(93) found that stress-management, mindfulness and talking 
466 therapies may offer small to moderate improvements in BI however there is a 
467 lack of evidence from good randomised controlled trials.
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468 Future Research
469 Future research should focus on developing a consensus around which 
470 validated tool or tools are best suited to measuring BID in an IBD population. 
471 Whilst we describe validity of tools such as the Body Image Scale, we have not 
472 independently verified this, therefore we could not recommend a particular tool. 
473 Defining thresholds may allow estimation of the prevalence of BID in this 
474 population. Establishing reference values in a healthy population would allow for 
475 more meaningful interpretation of BID scores across different chronic diseases. 
476 Enrolling patients from diagnosis and following them over time would be useful 
477 to measure how BI changes with duration, activity of disease and treatment. 
478 Whilst more severe IBD symptoms or invasive treatment options may 
479 exacerbate BID, BID itself and any associated anxiety or depressive symptoms 
480 may in turn exacerbate IBD symptoms(94, 95), and future research should also 
481 address this association. If BID is recognised and treated early it may contribute 
482 to preventing worsening disease course. It may also be useful to encourage the 
483 use of BI as a patient reported outcome in future IBD studies. This would 
484 increase data on BID and lead to a greater understanding of the condition.  
485
486 CONCLUSION
487 In conclusion, the evidence suggests a detrimental effect of IBD on BI, but 
488 uncertainty remains due a lack of comparison data from healthy populations. 
489 Associations of BID with disease-related factors such as steroid treatment, 
490 fatigue, disease activity and surgery are apparent and findings suggest a 
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491 correlation between impaired BI and poorer QoL. These results should be 
492 cautiously interpreted due to risk of bias and/or poor reporting of methodological 
493 criteria amongst included studies, and the wide variation between populations, 
494 BI tools, and scoring systems. Future studies should make use of validated 
495 measurement tools and include BI as a main outcome where appropriate.
496
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784 Figures
785 1. The selection process of records for inclusion/exclusion detailed in a PRISMA 
786 flowchart. 
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Supplementary Data Content - Table 1
MEDLINE Search Strategy – OVID MEDLINE In process & other non-indexed citations and 
OVID MEDLINE.
Search Query
#1 exp inflammatory bowel diseases/
#2 inflammatory bowel disease*.mp.
#3 exp Colitis, Ulcerative/
#4 ulcerative colitis.mp.
#5 exp Crohn disease/
#6 Crohn* disease.mp.
#7 Crohn*.mp.
#8 IBD.mp.
#9 CD.mp.
#10 UC.mp.
#11 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10
#12 exp body image/
#13 body image.mp.
#14 body dissatisfaction.mp.
#15 body awareness.mp.
#16 body concern*.mp.
#17 body attitude*.mp.
#18 body preoccupation.mp.
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#19 body perception.mp.
#20 body anxiety.mp.
#21 body conscious*.mp.
#22 12 OR 13 OR 14 OR 15 OR 16 OR 17 OR 18 OR 19 OR 20 OR 21
#23 11 AND 22
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1 Supplementary Data Content - Table 2 Results of risk of bias assessment using Joanna Briggs Institute Tools
Study Was the 
sample frame 
appropriate 
to address 
the target 
population?
Were the 
criteria for 
inclusion in 
the sample 
clearly 
defined?
Were the 
study 
subjects 
and the 
setting 
described 
in detail?
Was the 
exposure 
measured 
in a valid 
and 
reliable 
way?
Were 
objective, 
standard 
criteria used 
for 
measureme
nt of the 
condition?
Were 
confou
nding 
factors 
identifie
d?
Were 
strategies 
to deal 
with 
confoundi
ng factors 
stated?
Were the 
outcomes 
measured 
in a valid 
and reliable 
way?
Was 
appropriate 
statistical 
analysis 
used?
Was the 
response rate 
adequate, and if 
not, was the low 
response rate 
managed 
appropriately? 
(>75%)
Abdovic et 
al (2013)
Yes Yes Yes Yes N/A No No Yes Yes Yes
Bel et al 
(2015)
Yes Yes Yes Yes N/A Yes Yes Yes Yes No
Beld et al 
(2010)
Yes Yes No Yes Yes No No No Yes Yes
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Study Was the 
sample frame 
appropriate 
to address 
the target 
population?
Were the 
criteria for 
inclusion in 
the sample 
clearly 
defined?
Were the 
study 
subjects 
and the 
setting 
described 
in detail?
Was the 
exposure 
measured 
in a valid 
and 
reliable 
way?
Were 
objective, 
standard 
criteria used 
for 
measureme
nt of the 
condition?
Were 
confou
nding 
factors 
identifie
d?
Were 
strategies 
to deal 
with 
confoundi
ng factors 
stated?
Were the 
outcomes 
measured 
in a valid 
and reliable 
way?
Was 
appropriate 
statistical 
analysis 
used?
Was the 
response rate 
adequate, and if 
not, was the low 
response rate 
managed 
appropriately? 
(>75%)
Bengtsson 
et al (2011)
Yes No No Yes Yes Unclear No Yes Yes No
Brown et al 
(2015)
Yes Yes Yes Yes Yes Unclear No No Yes No
Chouliaras 
et al (2017)
Yes Yes Yes Yes N/A Yes Yes Yes Yes Unclear
de Rooy et 
al (2001)
Unclear No Yes No N/A Yes Yes Yes Yes Unclear
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Study Was the 
sample frame 
appropriate 
to address 
the target 
population?
Were the 
criteria for 
inclusion in 
the sample 
clearly 
defined?
Were the 
study 
subjects 
and the 
setting 
described 
in detail?
Was the 
exposure 
measured 
in a valid 
and 
reliable 
way?
Were 
objective, 
standard 
criteria used 
for 
measureme
nt of the 
condition?
Were 
confou
nding 
factors 
identifie
d?
Were 
strategies 
to deal 
with 
confoundi
ng factors 
stated?
Were the 
outcomes 
measured 
in a valid 
and reliable 
way?
Was 
appropriate 
statistical 
analysis 
used?
Was the 
response rate 
adequate, and if 
not, was the low 
response rate 
managed 
appropriately? 
(>75%)
Dunker et al 
(1998)
No No Yes Unclear Unclear No No No Yes Yes
Dunker et al 
(2001)
Unclear No Unclear Yes Unclear Unclear Unclear No Yes Yes
Eshuis et al 
(2008)
Yes Unclear Yes Yes Yes Yes Yes No Yes Yes
Eshuis et al Unclear Yes Unclear Yes Yes No No No Yes Yes
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Study Was the 
sample frame 
appropriate 
to address 
the target 
population?
Were the 
criteria for 
inclusion in 
the sample 
clearly 
defined?
Were the 
study 
subjects 
and the 
setting 
described 
in detail?
Was the 
exposure 
measured 
in a valid 
and 
reliable 
way?
Were 
objective, 
standard 
criteria used 
for 
measureme
nt of the 
condition?
Were 
confou
nding 
factors 
identifie
d?
Were 
strategies 
to deal 
with 
confoundi
ng factors 
stated?
Were the 
outcomes 
measured 
in a valid 
and reliable 
way?
Was 
appropriate 
statistical 
analysis 
used?
Was the 
response rate 
adequate, and if 
not, was the low 
response rate 
managed 
appropriately? 
(>75%)
(2010)
Gallo et al 
(2014)
Yes Yes Yes Yes N/A No No Yes Yes Yes
Giudici et al 
(2017) 
No Unclear Unclear Unclear Unclear Unclear Unclear Unclear Unclear Unclear
Grootenhuis 
(2009)
Yes Yes Yes N/A Unclear Yes Yes No Yes No
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Study Was the 
sample frame 
appropriate 
to address 
the target 
population?
Were the 
criteria for 
inclusion in 
the sample 
clearly 
defined?
Were the 
study 
subjects 
and the 
setting 
described 
in detail?
Was the 
exposure 
measured 
in a valid 
and 
reliable 
way?
Were 
objective, 
standard 
criteria used 
for 
measureme
nt of the 
condition?
Were 
confou
nding 
factors 
identifie
d?
Were 
strategies 
to deal 
with 
confoundi
ng factors 
stated?
Were the 
outcomes 
measured 
in a valid 
and reliable 
way?
Was 
appropriate 
statistical 
analysis 
used?
Was the 
response rate 
adequate, and if 
not, was the low 
response rate 
managed 
appropriately? 
(>75%)
Kjaer et al 
(2014)
Unclear Unclear Yes Yes Unclear No No No Yes No
Kuruvilla et 
al (2012)
Yes Unclear Unclear Unclear Unclear Unclear Unclear Unclear Unclear Unclear
Lee et al 
(2015)
Yes Yes Yes Unclear Yes Yes Yes Yes Yes Unclear
Mason et al 
(2015)
Yes Yes Yes Yes N/A No No Yes Yes Unclear
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Study Was the 
sample frame 
appropriate 
to address 
the target 
population?
Were the 
criteria for 
inclusion in 
the sample 
clearly 
defined?
Were the 
study 
subjects 
and the 
setting 
described 
in detail?
Was the 
exposure 
measured 
in a valid 
and 
reliable 
way?
Were 
objective, 
standard 
criteria used 
for 
measureme
nt of the 
condition?
Were 
confou
nding 
factors 
identifie
d?
Were 
strategies 
to deal 
with 
confoundi
ng factors 
stated?
Were the 
outcomes 
measured 
in a valid 
and reliable 
way?
Was 
appropriate 
statistical 
analysis 
used?
Was the 
response rate 
adequate, and if 
not, was the low 
response rate 
managed 
appropriately? 
(>75%)
Maunder et 
al (1999)
Unclear Unclear Yes Yes N/A No No Yes Yes Unclear
McDermott 
et al (2015)
Yes Yes Unclear Unclear N/A Yes Yes Yes Yes Yes
Muller et al 
(2010)
Yes Yes Unclear Unclear N/A Yes Yes No Yes Unclear
Ogden et al Unclear Unclear Unclear Unclear N/A N/A N/A Yes Yes Yes
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Study Was the 
sample frame 
appropriate 
to address 
the target 
population?
Were the 
criteria for 
inclusion in 
the sample 
clearly 
defined?
Were the 
study 
subjects 
and the 
setting 
described 
in detail?
Was the 
exposure 
measured 
in a valid 
and 
reliable 
way?
Were 
objective, 
standard 
criteria used 
for 
measureme
nt of the 
condition?
Were 
confou
nding 
factors 
identifie
d?
Were 
strategies 
to deal 
with 
confoundi
ng factors 
stated?
Were the 
outcomes 
measured 
in a valid 
and reliable 
way?
Was 
appropriate 
statistical 
analysis 
used?
Was the 
response rate 
adequate, and if 
not, was the low 
response rate 
managed 
appropriately? 
(>75%)
(2011)
Perrin et al 
(2008)
Yes Yes Yes Unclear N/A N/A N/A Yes Yes No
Polle et al 
(2007)
Unclear Unclear Unclear Yes Unclear Yes No No Yes Yes
Ponsioen et 
al (2017)
Yes Yes Yes Yes Unclear Unclear Unclear Yes Unclear No
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Study Was the 
sample frame 
appropriate 
to address 
the target 
population?
Were the 
criteria for 
inclusion in 
the sample 
clearly 
defined?
Were the 
study 
subjects 
and the 
setting 
described 
in detail?
Was the 
exposure 
measured 
in a valid 
and 
reliable 
way?
Were 
objective, 
standard 
criteria used 
for 
measureme
nt of the 
condition?
Were 
confou
nding 
factors 
identifie
d?
Were 
strategies 
to deal 
with 
confoundi
ng factors 
stated?
Were the 
outcomes 
measured 
in a valid 
and reliable 
way?
Was 
appropriate 
statistical 
analysis 
used?
Was the 
response rate 
adequate, and if 
not, was the low 
response rate 
managed 
appropriately? 
(>75%)
Saha et al 
(2015)
Yes Yes Yes Yes N/A Yes Yes Unclear Yes No
Scarpa et al 
(2009)
Unclear Yes Unclear Yes Yes Yes Yes No Yes Yes
Shepanksi 
(2005)
Yes Unclear Unclear Yes Unclear Unclear No Yes Yes No
Trindade et 
al (2017)
Yes Yes Yes Unclear N/A Yes Yes Yes Yes Unclear
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Study Was the 
sample frame 
appropriate 
to address 
the target 
population?
Were the 
criteria for 
inclusion in 
the sample 
clearly 
defined?
Were the 
study 
subjects 
and the 
setting 
described 
in detail?
Was the 
exposure 
measured 
in a valid 
and 
reliable 
way?
Were 
objective, 
standard 
criteria used 
for 
measureme
nt of the 
condition?
Were 
confou
nding 
factors 
identifie
d?
Were 
strategies 
to deal 
with 
confoundi
ng factors 
stated?
Were the 
outcomes 
measured 
in a valid 
and reliable 
way?
Was 
appropriate 
statistical 
analysis 
used?
Was the 
response rate 
adequate, and if 
not, was the low 
response rate 
managed 
appropriately? 
(>75%)
Vlahou et al 
(2008)
Yes Unclear No Unclear N/A Yes Yes No Yes Unclear
Voermans et 
al (2010)
Unclear Yes Unclear Yes N/A No No No Yes Yes
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